PMGC Holdings Inc.
ELAB
Analytical Summary
PMGC Holdings Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.
5-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ |
|---|---|---|---|---|---|
| Revenue Growth YoY (%) | — | — |
123.5%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+1444%)
|
— | — |
| EPS Growth YoY (%) | — | — |
-111.6%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — |
| Net Income Growth YoY (%) |
-24.0%
Weak
↑
Weak
Improving
Year-over-year change in net income |
-45.2%
Weak
Weak
Year-over-year change in net income |
-138.9%
Weak
Weak
Year-over-year change in net income |
— | — |
| FCF Growth YoY (%) | — | — |
-154.8%
Weak
Weak
Year-over-year change in free cash flow |
— | — |
| Revenue CAGR 3Y (%) |
-8.3%
Weak
Weak
Compound annual revenue growth over 3 years |
— | — | — | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ |
|---|---|---|---|---|---|
| Effective Tax Rate (%) (%) |
-0.4%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — | — | — |
| Profit Margin (%) (%) | — | — |
-251.2%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-2193%)
|
-234.9%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-2058%)
|
— |
| FCF Margin (%) (%) | — | — |
-266.1%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-207.0%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
| FCF / Net Income (x) |
0.82x
Caution
↓
Caution
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.88x
Caution
↓
Caution
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.06x
Fair
Fair
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.88x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ |
|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
-98.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-759%)
|
-93.8%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-725%)
|
-112.4%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-849%)
|
-159.1%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-1161%)
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ |
|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $590.08K | — | $1.71M | $766.28K | — |
| Depreciation Expense (USD) | $96.66K | $12.95K | $11.65K | $6.51K | — |
| Net Income, GAAP (USD) | $-7.75M | $-6.25M | $-4.30M | $-1.80M | — |
| Operating Cash Flow (USD) | $-5.93M | $-5.49M | $-4.56M | $-1.59M | — |
Secondary lens
Benchmark Lens
Compare ELAB against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare ELAB against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for ELAB
No bullish signals detected
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How ELAB compares to all companies
Peer Comparison
ELAB vs similar peers
Compare ELAB with peers
Stack ELAB against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 5 years · 18 quarters